Sign in

CIK 0001796280 · Non-accelerated filer

Oric Pharmaceuticals, Inc.

Sign in to watch
Ticker
ORIC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
471787157
Phone
(650) 388-5600
Business address
240 E. GRAND AVE., 2ND FLOOR, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,519,090
in 5 filings, $1.5M under 10b5-1 plans

Net −$1,519,090. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 51 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-12-16 Chacko Jacob PRESIDENT AND CEO Sale −24,660 $8.28 $204K 778,648
2024-12-15 Piscitelli Dominic Chief Financial Officer Option exercise +24,042 115,615
2024-12-15 Piscitelli Dominic Chief Financial Officer Option exercise · Restricted Stock Unit −6,042 0
2024-12-15 Piscitelli Dominic Chief Financial Officer Option exercise · Restricted Stock Unit −8,000 8,000
2024-12-15 Piscitelli Dominic Chief Financial Officer Option exercise · Restricted Stock Unit −10,000 20,000
2024-12-15 Multani Pratik S Chief Medical Officer Option exercise +24,042 55,615
2024-12-15 Multani Pratik S Chief Medical Officer Option exercise · Restricted Stock Unit −6,042 0
2024-12-15 Multani Pratik S Chief Medical Officer Option exercise · Restricted Stock Unit −8,000 8,000
2024-12-15 Multani Pratik S Chief Medical Officer Option exercise · Restricted Stock Unit −10,000 20,000
2024-12-15 Chacko Jacob PRESIDENT AND CEO Option exercise +67,000 803,308
2024-12-15 Chacko Jacob PRESIDENT AND CEO Option exercise · Restricted Stock Unit −16,667 0
2024-12-15 Chacko Jacob PRESIDENT AND CEO Option exercise · Restricted Stock Unit −22,000 22,000
2024-12-15 Chacko Jacob PRESIDENT AND CEO Option exercise · Restricted Stock Unit −28,333 56,667
2024-06-12 You Angie Director Grant or award · Stock Option (right to buy) +25,600 25,600
2024-06-12 Kunkel Lori Anne Director Grant or award · Stock Option (right to buy) +25,600 25,600
2024-06-12 Hoerter Steven L. Director Grant or award · Stock Option (right to buy) +25,600 25,600
2024-06-12 Dier Mardi Director Grant or award · Stock Option (right to buy) +25,600 25,600
2024-06-12 Heyman Richard A. Director Grant or award · Stock Option (right to buy) +25,600 25,600
2024-06-03 Kunkel Lori Anne Director Option exercise +20,500 $3.75 $77K 20,500
2024-06-03 Kunkel Lori Anne Director Option exercise · Stock Option (right to buy) −20,500 33,200

Page 6 of 12 · 228 trades